90Y-DOTATOC
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 90Y-DOTATOC, covering 2017-08-25 to 2018-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas [Phase 2]